Kar Therapeutics & Estates Private Limited

Kar Therapeutics & Estates Private Limited - pharma in Hyderabad., Telangana, India. FY 2026 financials and compliance.
CIN U24233TG1995PTC020683 Incorporated 14 June 1995 ROC Hyderabad HQ Hyderabad., Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹61.34 Lakh
▼ 2.00% YoY
EBITDA · FY 2025
*****
▲ 13.00% YoY
Net profit · FY 2025
*****
▲ 23.00% YoY
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹29.98 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
31 yrs
Est. 1995
Last financials
Mar 2025
Balance sheet date

About Kar Therapeutics & Estates Private Limited

Data last updated: 08 February 2026

Kar Therapeutics & Estates Private Limited is a private limited company based in Hyderabad., Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 14 June 1995, the company has been in operation for over 31 years.

Registered with ROC Hyderabad under CIN U24233TG1995PTC020683.

Capital: an authorised share capital of ₹30 Cr and a paid-up capital of ₹29.98 Cr. Formerly known as Dr.Reddy'S Estates Private Limited. It is led by directors Satish Reddy Kallam and Kallam Deepti Reddy.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 7 – 1 – 27 Ameerpet Hyderabad., Telangana, India.

As per the financials filed for FY 2025, the company reported a revenue of ₹61.34 Lakh, a decline of 2% compared to the previous year.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Kar Therapeutics & Estates Private Limited
CIN U24233TG1995PTC020683
Registration Number 020683
Incorporation Date 14 June 1995
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Satish Reddy Kallam Director Kallam Deepti Reddy Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    7 – 1 – 27 Ameerpet Hyderabad., Telangana, India
  • Industry
    Pharma, Drug Formulation & Development
Company report
Kar Therapeutics & Estates Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Kar Therapeutics & Estates Private Limited report

Financials, compliance, directors, charges, ownership and filings for Kar Therapeutics & Estates Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Kar Therapeutics & Estates Private Limited

Kar Therapeutics & Estates Private Limited has one previous CIN (Corporate Identification Number): U24233AP1995PTC020683. The current CIN is U24233TG1995PTC020683, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24233TG1995PTC020683 Current
U24233AP1995PTC020683 Previous

Business Activity of Kar Therapeutics & Estates Private Limited

Kar Therapeutics & Estates Private Limited is engaged in principal business activities including real estate and manufacturing, with detailed activities including real estate activities with own or leased property, food, beverages and tobacco products. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
L Real Estate L1 Real estate activities with own or leased property *********
C Manufacturing C1 Food, beverages and tobacco products *********

Auditor Details of Kar Therapeutics & Estates Private Limited

Kar Therapeutics & Estates Private Limited is audited by SATYANARAYANA & CO for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
SATYANARAYANA & CO blur-value blur-value blur-value

Board of Directors of Kar Therapeutics & Estates Private Limited

Kar Therapeutics & Estates Private Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Satish Reddy Kallam
Also directs: Vsd Holdings & Advisory Llp, Omez Real Estates Llp, Dr.Reddy's Laboratories Ltd and 5 more
Director 14 Jun 1995 31 Years 0 Months Current
Kallam Deepti Reddy
Also directs: Vsd Holdings & Advisory Llp, Omez Real Estates Llp, Shravya Publications Private Limited and 5 more
Director 28 Jul 1995 30 Years 11 Months Current
View all directors

Financials of Kar Therapeutics & Estates Private Limited FY 2025 filings available

Kar Therapeutics & Estates Private Limited reported revenue of ₹61.34 Lakh (down 2% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹61.34 Lakh ▼ -2%
Profit
***** ▲ 23%
EBITDA
***** ▲ 13%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Kar Therapeutics & Estates Private Limited

As of FY 2020, Kar Therapeutics & Estates Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings Kar Therapeutics & Estates Private Limited

Kar Therapeutics & Estates Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Kar Therapeutics & Estates Private Limited

View historical data on people associated with Kar Therapeutics & Estates Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Kar Therapeutics & Estates Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Kar Therapeutics & Estates Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Kar Therapeutics & Estates Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Kar Therapeutics & Estates Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Kar Therapeutics & Estates Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Kar Therapeutics & Estates Private Limited

MSME Payment Delays by Kar Therapeutics & Estates Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Kar Therapeutics & Estates Private Limited

Subsidiaries & Group Companies of Kar Therapeutics & Estates Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Kar Therapeutics & Estates Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Kar Therapeutics & Estates Private Limited

MCA Filings & Documents of Kar Therapeutics & Estates Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Kar Therapeutics & Estates Private Limited

Directors
31 Jan 2026
Bhavyaa Gupta was appointed as a Company Secretary on 31 Jan 2026 & has been associated with this company since 5 months 12 days.
Activity
30 Sep 2025
Kar Therapeutics & Estates Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Kar Therapeutics & Estates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
28 Jul 1995
Kallam Deepti Reddy was appointed as a Director on 28 Jul 1995 & has been associated with this company since 30 years 11 months.
Directors
14 Jun 1995
Satish Reddy Kallam was appointed as a Director on 14 Jun 1995 & has been associated with this company since 31 years 30 days.
Activity
14 Jun 1995
Kar Therapeutics & Estates Private Limited was registered on 14 Jun 1995 with Roc Hyderabad & aged 31 years 30 days as per MCA records.

Frequently Asked Questions about Kar Therapeutics & Estates Private Limited

Kar Therapeutics & Estates Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 14 June 1995 (31+ years old) and is registered under CIN U24233TG1995PTC020683.

Kar Therapeutics & Estates Private Limited reported revenue of ₹61.34 Lakh for FY 2025 (down 2.00% YoY).

The current directors of Kar Therapeutics & Estates Private Limited are:

The primary industry of Kar Therapeutics & Estates Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Kar Therapeutics & Estates Private Limited can be reached at the registered office: 7 – 1 – 27 Ameerpet Hyderabad, Telangana, India.

The authorised capital is ₹30 Cr, and the paid-up capital is ₹29.98 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available